Effects of Nordic Walking and Exercise on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Type 2 Diabetes Exercise | Behavioral: Exercise on Prescription Behavioral: Nordic Walking | Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Investigator) Primary Purpose: Treatment |
| Official Title: | Effects of Nordic Walking and Exercise on Prescription on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled Trial |
- Glycated hemoglobin (HbA1c). [ Time Frame: Baseline, after 4 months, after 1 year ]
- Adherence, Anthropometry,Blood pressure, Lipid profile, VO2max and quality of life. [ Time Frame: Baseline, after 4 months, after 1 year ]
| Enrollment: | 68 |
| Study Start Date: | February 2005 |
| Study Completion Date: | December 2007 |
| Primary Completion Date: | October 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Standard written information on exercise
The Control group got the diabetes outpatients clinics standard written information on exercise as a part of the treatment for Type 2 Diabetes and were, like other Type 2 Diabetes patients in the clinic, advised at inclusion to be physically active.
|
|
|
Experimental: Exercise on Prescription
In Denmark, Exercise on Prescription have focused on individual behavioral change and an exercise program for 16 weeks. The physical training consisted of both aerobic and strength training and took place in supervised groups
|
Behavioral: Exercise on Prescription
The physical training consisted of both aerobic and strength training and took place in supervised groups.
|
|
Experimental: Nordic Walking
Nordic Walking is a fitness type of walking; incorporating the use of specially designed walking sticks. Nordic Walking focuses on aerobic training where the additional activity of the arms increases a person's oxygen uptake and energy expenditure.
|
Behavioral: Nordic Walking
Nordic Walking is a fitness type of walking; incorporating the use of specially designed walking sticks. Nordic Walking focuses on aerobic training where the additional activity of the arms increases a person's oxygen uptake and energy expenditure.
|
Detailed Description:
Physical training and exercise is considered a cornerstone in the treatment of Type 2 Diabetes Mellitus.
Programs which include physical activity as a component in the treatment of Type 2 Diabetes as well as other chronic diseases have in Denmark and other countries been based on "Exercise on Prescription schemes". In Denmark, these schemes have focused on individual behavioral change and an exercise program for 16 weeks. No studies have documented whether "Exercise on Prescription" helps patients with Type 2 Diabetes to change their lifestyle behavior or whether it has a positive impact on measurements for physical capacity and glucose metabolism.
Nordic Walking is a fitness type of walking; incorporating the use of specially designed walking sticks. Nordic Walking focuses on aerobic training where the additional activity of the arms increases a person's oxygen uptake and energy expenditure.
In Denmark, many activity programs and concepts such as Exercise on Prescription and Nordic Walking are recommended to patients with Type 2 Diabetes but their efficacy has not been demonstrated.
It is unknown whether one specific type of physical training program is more suitable than another, when comparing the physical effects as well as the ability to induce good compliance and change in lifestyle.
The aim of this randomized, controlled trial was to evaluate the effect of two different physical exercise programs lasting 4 months aiming at introducing long term life style changes in physical activity with a follow-up period of 8 months in patients with type 2 diabetes.
Eligibility
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 80 Years (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Type 2 Diabetes for more than one year,
- HbA1c in the range of 7-10 %,
- BMI > 25 kg/m2,
- Age 25-80 years
- Stable antidiabetic treatment for at least 3 month before inclusion.
Exclusion Criteria:
- Participants with symptomatic heart disease (NYHA 2-4)
- Ischemia in lower extremities,
- Myocardial infarction within the previous 3 months
- Lung disease
Contacts and Locations
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01085773
| Denmark | |
| Department of Endocrinology, Hospital of Southwest Denmark | |
| Esbjerg, Syddanmark, Denmark, 6700 | |
| Principal Investigator: | Bibi Gram, Ph.d student | University of Southern Denmark |
| Study Chair: | Jeppe Gram, MD, Ph.d. | Hospital of Southwest Denamark |
More Information
| ClinicalTrials.gov Identifier: | NCT01085773 History of Changes |
| Other Study ID Numbers: |
2628-04 |
| First Submitted: | March 11, 2010 |
| First Posted: | March 12, 2010 |
| Last Update Posted: | March 12, 2010 |
| Last Verified: | January 2005 |
Keywords provided by Hospital of South West Denmark:
|
HbA1c Type 2 Diabetes Lifestyle changes Exercise |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |